Finding extra comfort when a new cat joins my existing feline friend

Sex-related gap found for use of DMTs in MS patients ages 18-40

Despite evidence supporting the safety of disease-modifying therapies (DMTs) during pregnancy, women with multiple sclerosis (MS) in their childbearing years are significantly less likely than men in the same age range to receive these typically most effective treatments, according to a study from France. The researchers found what they…

Fatigue, cognition in MS patients aren’t barriers to healthy habits

Three self-reported prevalent symptoms among people with multiple sclerosis (MS) – fatigue, mobility issues, and cognitive impairment – are generally not associated with lower engagement in healthy lifestyle factors, a study in Australia shows. However, in the long term, mobility difficulties may significantly reduce adherence to physical activity, a…

How I handle depth perception and driving with MS

Have you ever been on a flight of stairs and misjudged the height of the steps, causing you to lose your footing? That happens to me more than I’d like to admit. This misjudgment stems from our depth perception, which is our ability to view the world in three dimensions,…

Guest Voice: Funding cuts for MS research tamper with our hope

Denise Schnieders is a wife, mom, teacher, volleyball coach, and passionate advocate living with multiple sclerosis (MS). Since her diagnosis, she’s become a powerful voice in the MS community, raising awareness, advocating for better healthcare policy, and pushing for more research funding. Through her platform, MSdopaminedressed, Schnieders shares…

Stem cell transplant may slow RRMS disease progression: Study

Autologous hematopoietic stem cell transplant (aHSCT) could slow disease progression in people with relapsing-remitting multiple sclerosis (RRMS), according to a study tracking MS patients in Sweden. The procedure was associated with sustained reductions in biomarkers linked to progressive MS. The results also showed that a significant portion of patients…

DMTs before, during MS pregnancy generally safe: Registry data

About 62% of multiple sclerosis (MS) patients use disease-modifying therapies (DMTs) before and during pregnancy, and the medications don’t appear to harm their health or their babies’ health, recently reported data from an international registry show. Most pregnancies resulted in live, full-term births, and these births generally occurred…

Organizing my health: How my pill box became a lifeline

Before 2016, I didn’t need to take any prescription medications, at least not regularly. But during my first episode of optic neuritis and a few years later, after my diagnosis of relapsing-remitting multiple sclerosis, I was forced to create a new habit. During that first episode of optic…

From practitioner to patient: My unexpected MS relapse

The night before I was supposed to teach an autoimmune nutrition class, I reentered a role I thought I’d finally outgrown. Instead of educating other practitioners in the functional medicine space, I found myself in the emergency room, listing symptoms I couldn’t fully untangle or explain. I wasn’t there…

Fumarate-based MS therapies have equal benefit for different races

Fumarate-based therapies like Tecfidera (dimethyl fumarate) and Vumerity (diroximel fumarate) are equally effective among Black, Hispanic, Asian, and white adults with relapsing forms of multiple sclerosis (MS) in the U.S., the largest real-world study of its kind shows. “The findings of this study suggest that fumarate medicines…

Fenebrutinib curbs brain lesions in MS, Phase 2 study finds

Fenebrutinib significantly reduced the occurrence of new brain lesions with active inflammation in people with relapsing multiple sclerosis (MS), a Phase 2 clinical trial found. In the open-label extension portion of the FENopta trial (NCT05119569), disease activity “remained very low” for nearly one year, researchers wrote, with 98%…

Cold sore virus may play role in MS, mouse study finds

A common virus that causes cold sores, herpes simplex virus type 1 (HSV-1), may contribute to multiple sclerosis (MS). That’s according to a study by researchers at the University of Illinois Chicago (UIC). In mice lacking a protein that helps control HSV-1, infection led to the degradation of the…

PAG-MS-guided exercise offers path to easing MS depression

Regular exercise that follows established guidelines for physical activity in multiple sclerosis (MS) leads to clinically meaningful gains in depression and supports its use as a nonpharmacological treatment for people with MS, a meta-analysis of 12 studies suggests. The meta-analysis, “Effects of meeting exercise guidelines on depression and…

Music therapy for MS may help with motivation, heat sensitivity

A six-week music therapy intervention significantly reduced psychosocial fatigue — or fatigue that interferes with a person’s motivation and ability to engage in social and daily activities — and heat sensitivity in people with multiple sclerosis (MS), according to data from a clinical trial. Participants who received music therapy…